HealthEquity Files 8-K for Disclosure and Exhibits
Ticker: HQY · Form: 8-K · Filed: May 28, 2024 · CIK: 1428336
| Field | Detail |
|---|---|
| Company | Healthequity, INC. (HQY) |
| Form Type | 8-K |
| Filed Date | May 28, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, financial-reporting
Related Tickers: HQY
TL;DR
HealthEquity filed an 8-K for standard disclosures and exhibits, no major news.
AI Summary
HealthEquity, Inc. filed an 8-K on May 28, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements for these sections.
Why It Matters
This filing indicates HealthEquity is fulfilling its reporting obligations with the SEC, providing transparency to investors regarding its financial information and disclosures.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any new risks or material changes.
Key Players & Entities
- HEALTHEQUITY, INC. (company) — Filer
- May 28, 2024 (date) — Date of Report
FAQ
What is the purpose of this 8-K filing by HealthEquity, Inc.?
The purpose of this 8-K filing is to report a Regulation FD Disclosure and to file Financial Statements and Exhibits.
What is the date of this report?
The date of the report is May 28, 2024.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.
What is HealthEquity, Inc.'s principal executive office address?
HealthEquity, Inc.'s principal executive offices are located at 15 West Scenic Pointe Drive, Suite 100, Draper, Utah 84020.
Does this filing indicate any changes to HealthEquity's former name or address?
The filing notes 'Not Applicable' for former name or former address, if changed since last report, implying no recent changes to report in this context.
Filing Stats: 440 words · 2 min read · ~1 pages · Grade level 10.7 · Accepted 2024-05-28 16:31:34
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share HQY The NASDAQ Global Select
Filing Documents
- hqy-20240528.htm (8-K) — 23KB
- 0001428336-24-000032.txt ( ) — 146KB
- hqy-20240528.xsd (EX-101.SCH) — 2KB
- hqy-20240528_lab.xml (EX-101.LAB) — 22KB
- hqy-20240528_pre.xml (EX-101.PRE) — 13KB
- hqy-20240528_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On May 28, 2024, HealthEquity, Inc. issued its 2024 Corporate Social Responsibility Report, which can be found at https://drq94yec07kda.cloudfront.net/downloads/HQY-2024-Corporate-Social-Responsibility-Report.pdf and is incorporated herein by reference. The information in this Item 7.01 is being furnished with the U.S. Securities and Exchange Commission (SEC) and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (formatted in Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEALTHEQUITY, INC. Date: May 28, 2024 By: /s/ James Lucania Name: James Lucania Title: Executive Vice President and Chief Financial Officer